Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5735127 | Behavioural Brain Research | 2017 | 28 Pages |
Abstract
On the 10th day both doses were increasing the WMI as compared to the vehicle-treated group. In both, trained and treated groups, D1R levels were significantly reduced while D2R levels were unchanged. DAT levels were comparable between all groups while phosphorylated DAT levels were increased in the trained group treated with 1Â mg/kg body weight. CE-125 as a probably non-neurotoxic compound and specific reuptake inhibitor was shown to increase performance (WMI) and modulation of the dopaminergic system is proposed as a possible mechanism of action.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Ahmed M. Hussein, Yogesh D. Aher, Predrag Kalaba, Nilima Y. Aher, Vladimir DragaÄeviÄ, Bojana Radoman, Marija IliÄ, Johann Leban, Tetyana Beryozkina, Abdel Baset M.A. Ahmed, Ernst Urban, Thierry Langer, Gert Lubec,